I-Ming Wang
Director - Translational Oncology Pfizer
Seminars
Tuesday 4th November 2025
Exploring Updates on Clinical Biomarkers Correlated to ADC Treatment Response
2:00 pm
- Summarizing results from biomarker results associated with clinical efficacy and adverse events
- Addressing the current gaps in biomarker technologies and capabilities to inform ADC treatment response and patient selection strategy
- Suggesting future directions for ADC biomarker technologies
